综合贫血项目与个体化治疗(CAPPT):在尼泊尔南部测试妇女小组、家庭咨询和铁补充对妊娠期血红蛋白影响的整群随机对照试验方案
该整群随机对照试验在尼泊尔南部平原的54个非连续整群中开展,比较常规产前保健与家庭访视、铁补充、参与式学习与行动小组加常规产前保健对妊娠30±2周血红蛋白的影响。干预组血红蛋白假设较对照组高≥0.4 g/dL,计划样本842名妇女,主要结局为血红蛋白浓度。
要点
- 整群随机对照试验,54个整群,样本842名妇女(每臂421名,平均每整群15.6名)。
- 干预包括两次家庭咨询(孕12-21周和22-26周)个体化铁叶酸剂量及每月参与式学习与行动小组会议。
- 主要结局为孕30±2周血红蛋白浓度,假设干预组较对照组高≥0.4 g/dL。
核心结论
- 研究结果将为尼泊尔政府制定增加铁叶酸依从性、改善饮食和减少妊娠期贫血的政策提供信息。
研究设计与样本
- 非盲整群随机对照试验,在尼泊尔南部Kapilbastu平原地区54个非连续整群(平均人口2582,范围1299-4865)中开展,设两个研究臂:对照臂接受常规产前保健,干预臂接受家庭访视、铁补充、参与式学习与行动小组加常规产前保健。
- 参与者为同意月经监测、当地居民、已婚、年龄13-49岁且能回答问题的妇女;在1-2次月经缺失且妊娠试验阳性后,同意参加、孕周<20周且计划本地居住大部分孕期的妇女入组随访。
- 计划样本842名妇女(每臂421名,平均每整群15.6名),假设标准差1.2、组内相关系数0.09和整群大小变异系数0.27,提供88%把握度。
- 采用限制性随机化分配整群至研究臂,确保整群大小、民族、宗教和距卫生机构距离相似;分析为个体水平意向性治疗分析,使用混合效应回归。
主要发现
- 主要结局为孕30±2周血红蛋白浓度(g/dL);次要结局包括贫血患病率(%)、中上臂围(cm)、微量营养素充足平均概率(MPA)和卫生机构产前保健次数。
- 影响路径指标包括妊娠期铁叶酸片消耗数、能量摄入(kcal/天)和膳食铁摄入(mg/天)、生物利用度促进行为评分及一项营养知识指标回忆。
- 将从提供者视角估算干预成本和成本效果。
关键数值与推荐
- 假设干预臂孕30±2周血红蛋白较对照臂高≥0.4 g/dL。
- 样本842名妇女(每臂421名,平均每整群15.6名)在标准差1.2、组内相关系数0.09和整群大小变异系数0.27假设下提供88%把握度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anaemia in pregnancy remains prevalent in Nepal and causes severe adverse health outcomes. METHODS: This non-blinded cluster-randomised controlled trial in the plains of Nepal has two study arms: (1) Control: routine antenatal care (ANC); (2) Home visiting, iron supplementation, Participatory Learning and Action (PLA) groups, plus routine ANC. Participants, including women in 54 non-contiguous clusters (mean 2582; range 1299-4865 population) in Southern Kapilbastu district, are eligible if they consent to menstrual monitoring, are resident, married, aged 13-49 years and able to respond to questions. After 1-2 missed menses and a positive pregnancy test, consenting women < 20 weeks' gestation, who plan to reside locally for most of the pregnancy, enrol into trial follow-up. Interventions comprise two home-counselling visits (at 12-21 and 22-26 weeks' gestation) with iron folic acid (IFA) supplement dosage tailored to women's haemoglobin concentration, plus monthly PLA women's group meetings using a dialogical problem-solving approach to engage pregnant women and their families. Home visits and PLA meetings will be facilitated by auxiliary nurse midwives. The hypothesis is as follows: Haemoglobin of women at 30 ± 2 weeks' gestation is ≥ 0.4 g/dL higher in the intervention arm than in the control. A sample of 842 women (421 per arm, average 15.6 per cluster) will provide 88% power, assuming SD 1.2, ICC 0.09 and CV of cluster size 0.27. Outcomes are captured at 30 ± 2 weeks gestation. Primary outcome is haemoglobin concentration (g/dL). Secondary outcomes are as follows: anaemia prevalence (%), mid-upper arm circumference (cm), mean probability of micronutrient adequacy (MPA) and number of ANC visits at a health facility. Indicators to assess pathways to impact include number of IFA tablets consumed during pregnancy, intake of energy (kcal/day) and dietary iron (mg/day), a score of bioavailability-enhancing behaviours and recall of one nutrition knowledge indicator. Costs and cost-effectiveness of the intervention will be estimated from a provider perspective. Using constrained randomisation, we allocated clusters to study arms, ensuring similarity with respect to cluster size, ethnicity, religion and distance to a health facility. Analysis is by intention-to-treat at the individual level, using mixed-effects regression. DISCUSSION: Findings will inform Nepal government policy on approaches to increase adherence to IFA, improve diets and reduce anaemia in pregnancy. TRIAL REGISTRATION: ISRCTN 12272130 .
引用
- Saville NM, Kharel C, Morrison J, et al. Comprehensive Anaemia Programme and Personalized Therapies (CAPPT): protocol for a cluster-randomised controlled trial testing the effect women's groups, home counselling and iron supplementation on haemoglobin in pregnancy in southern Nepal. Trials. 2022. PMID: 35232469. doi:10.1186/s13063-022-06043-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。